A randomized controlled trial of pregnancy outcome of sequential versus day 3 and day 5 embryo transfer in cases with recurrent implantation failure

A randomized controlled trial of pregnancy outcome of sequential versus day 3 and day 5 embryo transfers in cases with recurrent implantation failure

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201709002592834

Enrollment

210

Registered

2017-09-07

Start date

2015-04-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth Embryo transfer, IVF/ICSI

Interventions

Sequential embryo transfer

Day 3 embryo transfer

Day 5 embryo transfer

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Age 35 years or less Normal endometrial cavity on hysteroscopy Recurrent (2 or more) implantation failure Negative thrombophilia screening No hydrosalpinx No endometriosis Day 3 FSH < 10IU/L and Estradiol <80 pg/mL Antimullerian hormone 1-3 ng/mL Availability of at least 5 embryos on postfertilization check

Exclusion criteria

Exclusion criteria: Patients not fulfilling the inclusion criteria Poor or over responders in a previous cycle or by ovarian reserve tests.

Design outcomes

Primary

Measure	Time frame
Implantation rate;Clinical pregnancy rate	—

Secondary

Measure	Time frame
Miscarriage rate;Multiple pregnancy rate;live birth rate	—

Countries

Egypt

Contacts

Public ContactHaitham Torky

October 6th University

haithamtorky@yahoo.com+201001230161

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026